Concepedia

Kathryn A. Kimmel

KA

Statistics

Publications

8

Citations

555

H-Index

8

Active since

1983

Affiliations

University of Michigan(Current)

University of Colorado Health

Roosevelt Institute

Kathryn A. Kimmel is an author at University of Michigan specializing in monoclonal antibodies, tumor antigens, and life sciences.

Publications per year

1983–2006

8

Publications

8

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours

M. Cianfrocca, Kathryn A. Kimmel, James M. Gallo et al. · British Journal of Cancer · 2006 · 177 citations · Full text

, , +15

Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9.

Kathryn A. Kimmel, Thomas E. Carey · PubMed · 1986 · 140 citations

, , +17

Antibodies to human squamous cell carcinoma

Thomas E. Carey, Kathryn A. Kimmel, D. R. Schwartz et al. · Otolaryngology · 1983 · 75 citations

, , +17

A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine

Samir D. Undevia, Hedy L. Kindler, Linda Janisch et al. · Annals of Oncology · 2004 · 72 citations · Full text

, , +9

11p Deletions and breakpoints in squamous cell carcinoma: Association with altered reactivity with the UM‐E7 antibody

Carol R. Bradford, Kathryn A. Kimmel, Daniel L. Van Dyke et al. · Genes Chromosomes and Cancer · 1991 · 34 citations

, , +16

1–5 of 8